Arca Biopharma Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ABIO Nasdaq 2834 http://arcabio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arca Biopharma Inc

ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19 - Sep 16th, 2021 12:30 pm
ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th - Aug 16th, 2021 12:05 pm
We Think ARCA biopharma (NASDAQ:ABIO) Can Afford To Drive Business Growth - Aug 12th, 2021 5:15 am
ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2 - Aug 9th, 2021 12:00 pm
ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update - Aug 4th, 2021 8:15 pm
Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Circulation: Arrhythmia and Electrophysiology - Jul 28th, 2021 12:00 pm
ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19 - Jul 13th, 2021 12:00 pm
ARCA biopharma to Present at Access to Giving Virtual Investor Conference on July 13th - Jul 9th, 2021 12:00 pm
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021 - Jul 8th, 2021 3:20 pm
ARCA biopharma Announces rNAPc2 COVID-19 Patent Assignment Agreement - Jul 7th, 2021 12:00 pm
ARCA biopharma Announces First Quarter 2021 Financial Results and Provides Corporate Update - May 11th, 2021 8:15 pm
Christopher Graybill Joins ARCA as Vice President, Clinical Development - May 5th, 2021 8:05 pm
ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial Officer - May 3rd, 2021 8:30 pm
ARCA biopharma Announces 2020 Financial Results and Provides Corporate Update - Mar 18th, 2021 8:30 pm
Here's Why We're Not Too Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Situation - Feb 13th, 2021 6:09 am
ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19 - Dec 15th, 2020 1:30 pm
ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders - Dec 9th, 2020 10:40 pm
AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation - Nov 23rd, 2020 1:30 pm
ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update - Nov 2nd, 2020 1:30 pm